Mead Johnson Nutrition 10-Q 24 Oct 13 2013 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 21, 2013
Document and Entity Information
Entity Registrant Name	Mead Johnson Nutrition Co
Entity Central Index Key	1452575
Document Type	10-Q
Document Period End Date	30-Sep-13
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Entity Common Stock, Shares Outstanding		201,985,119

CONSOLIDATED_STATEMENTS_OF_EAR

CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
NET SALES	$1,046.80	$921.30	$3,140	$2,920.20
Cost of Products Sold	365.5	357.5	1,140.80	1,103.30
GROSS PROFIT	681.3	563.8	1,999.20	1,816.90	1,999.20
Expenses:
Selling, General and Administrative	222.6	210.7	666.8	642.2
Advertising and Promotion	163.8	138.8	475.9	413.3
Research and Development	24.8	21.5	74.5	67.6
Other Expenses/(Income)—net	31.4	9.6	62.6	13.5
EARNINGS BEFORE INTEREST AND INCOME TAXES	238.7	183.2	719.4	680.3
Interest Expense-net	12.3	16.9	38.9	49
EARNINGS BEFORE INCOME TAXES	226.4	166.3	680.5	631.3	680.5
Provision for Income Taxes	66.4	27.1	182.4	151.2
NET EARNINGS	160	139.2	498.1	480.1
Less Net Earnings/(Loss) Attributable to Noncontrolling Interests	-1.6	-1.1	1.8	9.8
NET EARNINGS ATTRIBUTABLE TO SHAREHOLDERS	$161.60	$140.30	$496.30	$470.30
Earnings per Share-Basic
Net Earnings Attributable to Shareholders (in dollars per share)	$0.80	$0.69	$2.45	$2.30
Earnings per Share-Diluted
Net Earnings Attributable to Shareholders (in dollars per share)	$0.79	$0.69	$2.44	$2.29
Weighted Average Shares - Diluted	202.8	204.3	203.1	204.5
Dividends Declared per Share (in dollars per share)	$0.34	$0.30	$1.02	$0.90

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
NET EARNINGS	$160	$139.20	$498.10	$480.10
Foreign Currency Translation Adjustments
Translation Adjustments	-4.9	25.6	-66.8	-4.2
Tax Benefit/(Expense)	-0.6	-17.5	4	-12.2
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the Period	1.2	-5.4	5.2	-9.5
Reclassification Adjustment for (Gains)/Losses Included in Net Earnings	-0.5	-0.4	5.7	-0.9
Tax Benefit/(Expense)	-0.2	1.7	-3	3.1
Pension and Other Postretirement Benefits
Deferred Gains on Pension and Other Postretirement Benefits	0	0	0.8	0
Reclassification Adjustment for Losses Included in Net Earnings	4.5	5.9	23.9	18.4
Tax Benefit/(Expense)	0.5	-2.2	-6.6	-5.4
OTHER COMPREHENSIVE INCOME/(LOSS)			-25.7	-10.7
COMPREHENSIVE INCOME	160	146.9	461.3	469.4
Less Comprehensive Income/(Loss) Attributable to Noncontrolling Interests	-3.8	-1.1	-7.3	9.8
COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREHOLDERS	163.8	148	468.6	459.6
Comp Inc Equity and Redeemable NCI [Member]
Pension and Other Postretirement Benefits
OTHER COMPREHENSIVE INCOME/(LOSS)	$0	$7.70	($36.80)	($10.70)

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
CURRENT ASSETS:
Cash and Cash Equivalents	$985.20	$1,042.10
Receivables-net of allowances of $5.9 and $7.6, respectively	405.3	364.6
Inventories	499.6	435.9
Deferred Income Taxes-net of valuation allowance	86.2	86.4
Income Taxes Receivable	41.3	26
Prepaid Expenses and Other Assets	63.1	60
Total Current Assets	2,080.70	2,015
Property, Plant, and Equipment-net	785.1	689.9
Goodwill	209.3	270.6
Other Intangible Assets-net	106.8	129.9
Deferred Income Taxes-net of valuation allowance	38.2	24.5
Other Assets	135.6	128.3
TOTAL	3,355.70	3,258.20
CURRENT LIABILITIES:
Short-term Borrowings	2.6	161
Accounts Payable	509.6	508.5
Dividends Payable	69.3	61.3
Note Payable	0	26
Accrued Expenses	226.7	220.4
Accrued Rebates and Returns	317.6	314.8
Deferred Income-current	23.6	36.1
Income Taxes-payable and deferred	81	41.8
Total Current Liabilities	1,230.40	1,369.90
Long-Term Debt	1,516.80	1,523.20
Deferred Income Taxes-noncurrent	16	15.9
Pension, Postretirement and Postemployment Liabilities	184.4	188.8
Other Liabilities	141.9	95.1
Total Liabilities	3,089.50	3,192.90
COMMITMENTS AND CONTINGENCIES
REDEEMABLE NONCONTROLLING INTEREST	46.1	36.3
Shareholders' Equity
Common Stock, $0.01 par value: 3,000 authorized, 206.7 and 206.0 issued, respectively	2.1	2.1
Additional Paid-in/(Distributed) Capital	-630.7	-676.6
Retained Earnings	1,392.60	1,124.80
Treasury Stock-at cost	-339.1	-244.6
Accumulated Other Comprehensive Loss	-214.7	-187
Total Shareholders' Equity	210.2	18.7
Noncontrolling Interests	9.9	10.3
Total Equity	220.1	29
TOTAL	$3,355.70	$3,258.20

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Millions, except Per Share data, unless otherwise specified
Statement of Financial Position [Abstract]
Receivables, allowances (in dollars)	$5.90	$7.60
Common Stock, par value (in dollars per share)	$0.01	$0.01
Common Stock, authorized	3,000	3,000
Common Stock, issued	206.7	206

CONSOLIDATED_STATEMENTS_OF_EQU

CONSOLIDATED STATEMENTS OF EQUITY/(DEFICIT) AND REDEEMABLE NONCONTROLLING INTEREST (USD $)	Total	Redeemable Noncontrolling Interest	Common Stock	Additional Paid-in (Distributed) Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Noncontrolling Interests
In Millions, unless otherwise specified
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2011	$0
BALANCE at Dec. 31, 2011	-168		2.1	-728.4	770	-89.7	-133.1	11.1
Increase (Decrease) in Stockholders' Equity
Stock-based Compensation Awards	26.2			41.2		-15
Treasury Stock Acquired	-93.3					-93.3
Distributions to Noncontrolling Interests	-4							-4
Cash Dividends Declared	-183.8				-183.8
Net Earnings	479.2				470.3			8.9
Redeemable Noncontrolling Interest Accretion	-3.1				-3.1
Other Comprehensive Income (Loss)	-10.7						-10.7
Increase (Decrease) in Temporary Equity
Acquisition		30.2
Net earnings of redeemable noncontrolling interest		0.9
Redeemable Noncontrolling Interest Accretion		3.1
Redeemable Noncontrolling Interest, BALANCE at Sep. 30, 2012	34.2
BALANCE at Sep. 30, 2012	42.5		2.1	-687.2	1,053.40	-198	-143.8	16
Redeemable Noncontrolling Interest, BALANCE at Dec. 31, 2012	36.3
BALANCE at Dec. 31, 2012	29		2.1	-676.6	1,124.80	-244.6	-187	10.3
Increase (Decrease) in Stockholders' Equity
Stock-based Compensation Awards	28			45.9		-17.9
Treasury Stock Acquired	-76.6					-76.6
Distributions to Noncontrolling Interests	-3.7							-3.7
Cash Dividends Declared	-206.9				-206.9
Net Earnings	497.6				496.3			1.3
Redeemable Noncontrolling Interest Accretion	-21.6				-21.6
Other Comprehensive Income (Loss)	-25.7	-11.1					-27.7	2
Increase (Decrease) in Temporary Equity
Distributions to Noncontrolling Interests		-1.2
Net earnings of redeemable noncontrolling interest		0.5
Redeemable Noncontrolling Interest Accretion		21.6
Redeemable Noncontrolling Interest, BALANCE at Sep. 30, 2013	46.1
BALANCE at Sep. 30, 2013	$220.10		$2.10	($630.70)	$1,392.60	($339.10)	($214.70)	$9.90

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Net Earnings	$498.10	$480.10
Adjustments to Reconcile Net Earnings to Net Cash Provided by Operating Activities:
Depreciation and Amortization	62.1	56.7
Other	36.9	23.5
Changes in Assets and Liabilities	1	-95.3
Pension and Other Postretirement Benefits Contributions	-6.1	-24.9
Net Cash Provided by Operating Activities	592	440.1
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments for Capital Expenditures	-177.3	-85.7
Proceeds from Sale of Property, Plant and Equipment	2	1.2
Proceeds from Sale of Intangible Assets	0	5.5
Investment in Other Companies	-2.7	-3.3
Acquisition	0	-106.1
Net Cash Used in Investing Activities	-178	-188.4
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Short-term Borrowings	6.8	385.2
Repayments of Short-term Borrowings	-165	-230
Repayments of Notes Payable	-27.6	-26.8
Payments of Dividends	-198.9	-175.6
Stock-based-compensation-related Proceeds and Excess Tax Benefits	19.8	21
Purchases of Treasury Stock	-92.5	-108.3
Distributions to Noncontrolling Interests	-4.9	-2.2
Net Cash Used in Financing Activities	-462.3	-136.7
Effects of Changes in Exchange Rates on Cash and Cash Equivalents	-8.6	3.1
NET INCREAE/(DECREASE) IN CASH AND CASH EQUIVALENTS	-56.9	118.1
CASH AND CASH EQUIVALENTS:
Beginning of Period	1,042.10	840.3
End of Period	$985.20	$958.40

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	ORGANIZATION
	Mead Johnson Nutrition Company (“MJN” or the “Company”) manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. MJN has a broad product portfolio, which extends across routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. These products are generally sold to wholesalers, retailers and distributors and are promoted to healthcare professionals, and, where permitted by regulation and policy, directly to consumers.

ACCOUNTING_POLICIES

ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]
ACCOUNTING POLICIES	ACCOUNTING POLICIES
	Basis of Presentation—The Company prepared the accompanying unaudited consolidated financial statements in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X issued by the Securities and Exchange Commission (“SEC”). Under those rules, certain footnotes and other financial information that are normally required by GAAP for annual financial statements have been condensed or omitted. The Company is responsible for the financial statements and the related notes included in this Form 10-Q.
	The consolidated financial statements include all of the normal and recurring adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2013 and December 31, 2012, results of operations for the three and nine months ended September 30, 2013 and 2012, and cash flows for the nine months ended September 30, 2013 and 2012. Intercompany balances and transactions have been eliminated. Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full-year operating results or future performance.
	The accounting policies used in preparing these consolidated financial statements are the same as those used to prepare the Company’s annual report on Form 10-K for the year ended December 31, 2012 (“2012 Form 10-K”) with the exception of our goodwill impairment testing policy which is discussed below. These unaudited consolidated financial statements and the related notes should be read in conjunction with the audited year-end financial statements and accompanying notes included in the Company’s 2012 Form 10-K.
	Goodwill—During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1, which did not result in any delay, acceleration or avoidance of an impairment charge. The Company believes that moving the goodwill impairment testing date to the third quarter is preferable because it better aligns the impairment testing with our annual and long-term planning timeline, which is a significant element in the testing process. The Company completed impairment testing in both the first and third quarters of 2013 and concluded that no impairment of goodwill exists (see Note 13).
	Recently Adopted Accounting Standards—In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, requiring entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. For significant reclassifications related to net income, the ASU required disclosure in the consolidated statement of earnings or within the footnotes. For other amounts, the ASU required a cross-reference to other disclosures that provide additional detail about those amounts. This ASU did not change the current requirements for reporting the consolidated statement of earnings or other comprehensive income in the financial statements. The Company adopted the required financial reporting presentation effective January 1, 2013.
	Recently Issued Accounting Standards—In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830), clarifying the applicable guidance for the release of the cumulative translation adjustment. ASU 2013-05 is effective for the Company in the period beginning January 1, 2014. The Company does not expect the adoption of this update to have a material effect on the consolidated financial statements.
	In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or Tax Credit Carryforward Exists. ASU 2013-11 requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. ASU 2013-11 is effective for the Company in the period beginning January 1, 2014 and the Company does not anticipate that the adoption of this standard will have a material impact on its consolidated financial statements.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE
	The numerator for basic and diluted earnings per share is net earnings attributable to shareholders reduced by dividends and undistributed earnings attributable to unvested shares. The denominator for basic earnings per share is the weighted-average shares outstanding during the period. The denominator for diluted earnings per share is the weighted-average shares outstanding adjusted for the effect of dilutive stock options and performance share awards.
	The following table presents the calculation of basic and diluted earnings per share:
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions, except per share data)	2013			2012			2013			2012
	Basic earnings per share:
	Weighted-average shares outstanding	202.3			203.7			202.5			203.9
	Net earnings attributable to shareholders	$	161.6		$	140.3		$	496.3		$	470.3
	Dividends and undistributed earnings attributable to unvested shares	(0.3		)	(0.3		)	(1.0		)	(1.1		)
	Net earnings attributable to shareholders used for basic earnings per share calculation	$	161.3		$	140		$	495.3		$	469.2
	Net earnings attributable to shareholders per share	$	0.8		$	0.69		$	2.45		$	2.3
	Diluted earnings per share:
	Weighted-average shares outstanding	202.3			203.7			202.5			203.9
	Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	0.5			0.6			0.6			0.6
	Weighted-average shares — diluted	202.8			204.3			203.1			204.5
	Net earnings attributable to shareholders	$	161.6		$	140.3		$	496.3		$	470.3
	Dividends and undistributed earnings attributable to unvested shares	(0.3		)	(0.3		)	(1.0		)	(1.1		)
	Net earnings attributable to shareholders used for diluted earnings per share calculation	$	161.3		$	140		$	495.3		$	469.2
	Net earnings attributable to shareholders per share	$	0.79		$	0.69		$	2.44		$	2.29
	Potential shares outstanding from all stock-based awards were 2.9 million and 2.8 million as of September 30, 2013 and 2012, respectively. Of these shares, 2.4 million and 2.2 million were not included in the diluted earnings per share calculation for the three months ended September 30, 2013 and 2012, respectively, and 2.3 million and 2.2 million were not included in the diluted earnings per share calculation for the nine months ended September 30, 2013 and 2012.

INCOME_TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES
	For the three and nine months ended September 30, 2013, the effective tax rate (“ETR”) was 29.4% and 26.8%, respectively, compared with 16.3% and 24.0% for the same periods in 2012. The ETR increase was primarily due to the prior year change in management's assertion regarding certain foreign earnings and profits that are permanently invested abroad, favorable U.S. return-to-provision adjustments recorded in the prior year and the administrative penalty related to the China Antitrust Review (as defined in Note 8) which is non-deductible for tax purposes.
	The Company’s gross reserve for uncertain tax positions related to foreign and domestic matters, including penalties and interest, as of September 30, 2013 and December 31, 2012, was $102.8 million and $75.9 million, respectively. The Company believes that it has adequately provided for all uncertain tax positions. It is reasonably possible that new issues may be raised by tax authorities and that these issues may require increases in the balance of uncertain tax positions.
	Pursuant to the Amended and Restated Tax Matters Agreement dated December 18, 2009, Bristol-Myers Squibb Company (“BMS”), the Company’s former parent, maintains responsibility for all uncertain tax positions which may exist in the pre-initial public offering period or which may exist as a result of the initial public offering transaction. The Company has recorded a receivable from BMS for uncertain tax positions, including penalties and interest, of $8.8 million and $8.5 million as of September 30, 2013 and December 31, 2012 respectively.

SEGMENT_INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]
SEGMENT INFORMATION	SEGMENT INFORMATION
	MJN operates in four geographic operating segments: Asia, Europe, Latin America and North America. This operating segmentation is how the chief operating decision maker regularly assesses information for decision making purposes, including allocation of resources. Due to similarities in the economics, products offered, production process, customer base, and regulatory environment, these operating segments have been aggregated into two reportable segments: Asia/Latin America and North America/Europe.
	During the fourth quarter of 2012, the Company implemented a change in its organizational structure involving the transfer of its Puerto Rican operations from North America to Latin America. This change did not impact Europe or Asia and did not have a material impact on the assets of North America or Latin America. Segment information, for all periods presented, has been revised to be consistent with the new basis of presentation.
	Corporate and Other consists of unallocated general and administrative expenses; global business support activities, including research and development, marketing and supply chain costs; and income or expenses incurred within the operating segments that are not reflective of ongoing operations and affect the comparability of the operating segments’ results.
	The following table summarizes net sales and earnings before interest and income taxes for each of our reportable segments:
		Three Months Ended September 30,										Nine Months Ended September 30,
		Net Sales				Earnings Before Interest and Income Taxes						Net Sales				Earnings Before Interest and Income Taxes
	(In millions)	2013		2012		2013			2012			2013		2012		2013			2012
	Asia/Latin America	$	768	$	646.7	$	262		$	193.1		$	2,280.70	$	2,056.00	$	770		$	713.9
	North America/Europe	278.8		274.6		63			53.2			859.3		864.2		187.7			157.2
	Total reportable segments	1,046.80		921.3		325			246.3			3,140.00		2,920.20		957.7			871.1
	Corporate and Other	—		—		(86.3		)	(63.1		)	—		—		(238.3		)	(190.8		)
	Total	$	1,046.80	$	921.3	$	238.7		$	183.2		$	3,140.00	$	2,920.20	$	719.4		$	680.3

EMPLOYEE_STOCK_BENEFIT_PLANS

EMPLOYEE STOCK BENEFIT PLANS	9 Months Ended
	Sep. 30, 2013
EMPLOYEE STOCK BENEFIT PLANS [Abstract]
EMPLOYEE STOCK BENEFIT PLANS	EMPLOYEE STOCK BENEFIT PLANS
	The following table summarizes stock-based compensation expense related to stock options, performance share awards and restricted stock units.
		Three Months Ended September 30,							Nine Months Ended September 30,
	(In millions)	2013				2012			2013			2012
	Stock options	$	1.6			$	1.8		$	4.9		$	5.5
	Performance share awards	3.5				2			12.9			11.8
	Restricted stock units	2.2				2.1			7.9			6.5
	Total pre-tax stock-based compensation expense	$	7.3			$	5.9		$	25.7		$	23.8
	Net tax benefit related to stock-based compensation expense	$	(2.6	)		$	(2.5	)	$	(8.8	)	$	(9.1	)
	During the nine months ended September 30, 2013, the Company granted the following awards:
	(Shares in millions)	Shares Granted			Weighted-
					Average Grant
					Date Fair Value
	Stock options	0.5			$	15.08
	Performance share awards	0.2			$	72.53
	Restricted stock units	0.1			$	74.85
	As of September 30, 2013, the Company had the following award expense yet to be recognized:
	(Dollars and shares in millions)	Unrecognized				Expected
		Compensation				Weighted-Average
		Expense				Period to be
						Recognized
						(years)
	Stock options	$	9.2			2
	Performance share awards	$	10.1			1.4
	Restricted stock units	$	15.3			2.6

PENSION_AND_OTHER_POSTRETIREME

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	9 Months Ended
	Sep. 30, 2013
General Discussion of Pension and Other Postretirement Benefits [Abstract]
PENSION AND OTHER POST RETIREMENT BENEFIT PLANS	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
	The net periodic benefit cost of the Company’s defined benefit pension and postretirement benefit plans includes:
		Three Months Ended September 30,											Nine Months Ended September 30,
		Pension Benefits						Other Benefits					Pension Benefits						Other Benefits
	(In millions)	2013			2012			2013			2012		2013			2012			2013			2012
	Service cost – benefits earned during the period	$	1.3		$	1		$	0.3		$	0.2	$	3.9		$	2.9		$	0.8		$	0.7
	Interest cost on projected benefit obligations	3.6			3.8			0.4			0.4		10.8			11.7			1			1
	Expected return on plan assets	(4.1		)	(4.2		)	—			—		(12.3		)	(12.1		)	—			—
	Amortization of net actuarial loss	1.7			1.4			0.4			0.4		5			4			1.3			1.4
	Amortization of prior service benefit	—			—			(0.1		)	—		—			—			(0.1		)	(0.1		)
	Net periodic benefit cost	$	2.5		$	2		$	1		$	1	$	7.4		$	6.5		$	3		$	3
	Settlements	2.5			4.1			—			—		17.7			13.1			—			—
	Total net periodic benefit cost	$	5		$	6.1		$	1		$	1	$	25.1		$	19.6		$	3		$	3
	Settlements reflect the recognition of losses that were previously deferred within accumulated other comprehensive loss attributable to plan participants who have received lump sum distributions during the plan year. Recognition of settlements is triggered when the amount paid for lump sum distributions from a plan exceeds the sum of service and interest cost for the plan year. Losses reclassified to settlements for the nine months ended September 30, 2013 and 2012, respectively, were related to the U.S. plans and were recognized within other expenses/(income)-net on the consolidated statements of earnings.
	For the nine months ended September 30, 2013, the Company contributed $6.1 million to non-U.S. pension plans. For the nine months ended September 30, 2012, the Company contributed $24.9 million, primarily to the U.S. pension plan.

OTHER_EXPENSESINCOMENET

OTHER EXPENSES/(INCOME)-NET	9 Months Ended
	Sep. 30, 2013
Other Income and Expenses [Abstract]
Other Expense/(Income)-net Disclosure [Text Block]	OTHER EXPENSES/(INCOME) - NET
	The components of other expenses/(income) - net were:
		Three Months Ended September 30,					Nine Months Ended September 30,
	(In millions)	2013		2012			2013		2012
	Foreign exchange (gains)/losses - net	$	2.1	$	6.7		$	6.9	$	(2.1	)
	Administrative penalty (China)	26		—			33.4		—
	Pension settlements	2.5		4.1			17.7		13.1
	Gain on sale of certain non-core intangible assets	—		(5.5		)	—		(5.5		)
	Other - net	0.8		4.3			4.6		8
	Other expenses/(income) - net	$	31.4	$	9.6		$	62.6	$	13.5
	As announced by the Company on August 6, 2013, China’s National Development and Reform Commission (“NDRC”) assessed an administrative penalty against the Company in connection with the NDRC’s antitrust review of the infant formula industry’s resale pricing practices (“China Antitrust Review”). All amounts assessed were paid in the third quarter of 2013.

REDEEMABLE_NONCONTROLLING_INTE

REDEEMABLE NONCONTROLLING INTEREST	9 Months Ended
	Sep. 30, 2013
Business Combinations [Abstract]
ACQUISITION
	On March 15, 2012, the Company acquired 80% of the outstanding capital stock of Nutricion para el Conosur S.A. which manufactures, distributes and sells infant formula and children’s nutrition products in Argentina under the SanCor Bebé and Bebé Plus brands (the “Argentine Acquisition”). Under the terms of an agreement related to the Argentine Acquisition, the noncontrolling interest owner has the right to require MJN to purchase (the “Put Right”) its remaining 20% interest or to sell (the “Call Right”) up to an additional 20% of the outstanding capital stock of Nutricion para el Conosur S.A. The Put Right is exercisable from September 15, 2015 to September 15, 2018 and the decision to exercise is not within the control of MJN. The price paid upon exercise will be determined based on established multiples of sales and earnings of the acquired business and is currently estimated to equate to fair value at the earliest exercise date. As a result of the Put Right, the noncontrolling interest is presented as redeemable noncontrolling interest outside of equity on the balance sheet. Accretion to the redemption value of the Put Right will be recognized through equity using an interest method over the period from March 15, 2012 to September 15, 2015.

NET_EARNINGS_ATTRIBUTABLE_TO_N

NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS	9 Months Ended
	Sep. 30, 2013
Noncontrolling Interest [Abstract]
NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS	NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS
	Net earnings attributable to noncontrolling interests consists of a 20%, 11% and 10% interest held by third parties in operating entities in Argentina, China and Indonesia, respectively.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2013
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES
	The major categories of inventories were as follows:
	(In millions)	September 30, 2013		December 31, 2012
	Finished goods	$	286.3	$	264.6
	Work in process	85.8		56.9
	Raw and packaging materials	127.5		114.4
	Inventories	$	499.6	$	435.9

PROPERTY_PLANT_AND_EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT	PROPERTY, PLANT AND EQUIPMENT
	The major categories of property, plant and equipment were as follows:
	(In millions)	September 30, 2013			December 31, 2012
	Land	$	6.6		$	6
	Buildings	521.5			506
	Machinery, equipment and fixtures	638.6			595.7
	Construction in progress	214.7			150.4
	Accumulated depreciation	(596.3		)	(568.2		)
	Property, plant and equipment — net	$	785.1		$	689.9
	Construction in progress included investment primarily for the Company’s new spray dryer and technology center in Singapore (“Asia Spray Dryer Project”).

GOODWILL

GOODWILL	9 Months Ended
	Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL	GOODWILL
	The Company tests goodwill for impairment on an annual basis and whenever an event occurs or circumstances change that would, more likely than not, reduce the fair value of a reporting unit below its carrying amount. Historically, the Company’s policy was to perform the annual impairment test for goodwill as of January 1 of each year. The Company completed its annual impairment test in the first quarter of 2013 in accordance with this policy and concluded that no impairment existed. During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1 of each fiscal year to better align with the timing of its annual and long-term planning process, which is a significant input in the testing process. Accordingly, the Company believes this change is preferable. This change did not delay, accelerate or avoid an impairment charge. As a result of this change, impairment testing was completed during the third quarter of 2013 and the Company concluded that no impairment existed. This change was applied prospectively beginning July 1, 2013 and had no impact on the consolidated financial statements. The change was not applied retrospectively as it is impracticable to do so because retrospective application would have required the application of significant estimates and assumptions without the use of hindsight.
	For the nine months ended September 30, 2013 and 2012, the change in the carrying amount of goodwill by reportable segment, was primarily driven by the cumulative impact due to a correction of the currency denomination of the goodwill related to two reporting units. The revision had the impact of decreasing the Company’s total value of goodwill and decreasing the total currency translation adjustment included in the accumulated other comprehensive loss section of shareholders’ equity and other comprehensive income.
	For the nine months ended September 30, 2013 and 2012, the change in the carrying amount of goodwill by reportable segment, including the cumulative impact of the revisions described above, was as follows:
	(In millions)	Asia/			North America/			Total
		Latin America			Europe
	Balance as of January 1, 2013	$	253.6		$	17		$	270.6
	Redenomination	(42.5		)	2			(40.5		)
	Translation adjustments	(20.8		)	—			(20.8		)
	Balance as of September 30, 2013	$	190.3		$	19		$	209.3
	Balance as of January 1, 2012	$	115.8		$	1.7		$	117.5
	Acquisition	155.5			17.3			172.8
	Translation adjustments	(11.4		)	(1.3		)	(12.7		)
	Balance as of September 30, 2012	$	259.9		$	17.7		$	277.6
	As of September 30, 2013, the Company had no accumulated impairment loss.

OTHER_INTANGIBLE_ASSETS

OTHER INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2013
Intangible Assets, Net (Excluding Goodwill) [Abstract]
OTHER INTANGIBLE ASSETS	OTHER INTANGIBLE ASSETS
	The gross carrying value and accumulated amortization by class of intangible assets as of September 30, 2013 and December 31, 2012 were as follows:
		As of September 30, 2013							As of December 31, 2012
	(In millions)	Gross		Accumulated			Net Book		Gross		Accumulated			Net Book
		Carrying		Amortization			Value		Carrying		Amortization			Value
		Amount							Amount
	Indefinite-lived intangible assets:
	Trademark(1) .	$	38.5	$	—		$	38.5	$	45.3	$	—		$	45.3
	Non-compete agreement(1) .	7.6		—			7.6		8.9		—			8.9
	Sub-total	46.1		—			46.1		54.2		—			54.2
	Amortizable intangible assets:
	Computer software	132.2		(74.6		)	57.6		132.2		(60.2		)	72
	Distributor-customer relationship(1) .	3.7		(0.6		)	3.1		4.4		(0.7		)	3.7
	Sub-total	135.9		(75.2		)	60.7		136.6		(60.9		)	75.7
	Total other intangible assets	$	182	$	(75.2	)	$	106.8	$	190.8	$	(60.9	)	$	129.9
	(1) Changes in balances result from currency translation and amortization.
	The Company tests intangibles assets not subject to amortization for impairment on an annual basis and whenever a significant event occurs or circumstances change that indicate that it is more likely than not that the asset is impaired. To align with the change in the timing of its annual goodwill impairment test, the Company completed impairment testing as of both the first and third quarters of 2013 and concluded that no impairment of intangible assets not subject to amortization exists.

DEBT

DEBT	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]
DEBT	DEBT
	Short-Term Borrowings and Five-Year Revolving Credit Facility Agreement
	As of September 30, 2013, the Company’s short-term borrowings were $2.6 million and were for the Company’s legal entity based in Argentina. These short-term borrowings had a weighted-average interest rate of 22.00% as of September 30, 2013. The Company intends to repay these borrowings within 12 months and has the ability to do so. As of December 31, 2012, the Company’s short-term borrowings totaled $161.0 million and were primarily from the Company’s five-year revolving credit facility agreement (“Credit Facility”). For the nine months ended September 30, 2013, borrowings from the Credit Facility had a weighted-average interest rate of 1.53%.
	Borrowings from the Credit Facility are used for working capital and other general corporate purposes. The Credit Facility is unsecured and repayable on maturity in June 2016, subject to annual extensions if a sufficient number of lenders agree. The maximum amount of outstanding borrowings and letters of credit permitted at any one time under the Credit Facility is $500.0 million, which may be increased from time to time up to $750.0 million at the Company’s request and with the consent of the lenders, subject to satisfaction of customary conditions. The Credit Facility contains financial covenants, whereby the ratio of consolidated total debt to consolidated Earnings Before Interest, Income Taxes, Depreciation and Amortization (“EBITDA”) cannot exceed 3.25 to 1.0, and the ratio of consolidated EBITDA to consolidated interest expense cannot be less than 3.0 to 1.0. The Company was in compliance with these covenants as of September 30, 2013.
	Borrowings under the Credit Facility bear interest at a rate that is determined as a base rate plus a margin. The base rate is either (a) LIBOR for a specified interest period, or (b) a floating rate based upon JPMorgan Chase Bank’s prime rate, the Federal Funds rate or LIBOR. The margin is determined by reference to the Company’s credit rating. The margin can range from 0.075% to 1.45% over the base rate. In addition, the Company incurs an annual 0.2% facility fee on the entire facility commitment of $500.0 million.
	Note Payable
	On March 15, 2012, the Company completed the Argentine Acquisition described in Note 9. Of the ARS850.7 million purchase price payable in connection with the Argentine Acquisition, ARS377.6 million was financed through a note payable. The remaining balance of the note payable was paid on July 10, 2013. Through March 15, 2013, the annual interest rate for the note payable was 14%. Effective as of March 16, 2013, the note was converted to U.S. dollar-denominated indebtedness and the annual interest rate was automatically modified to be 0.85%, which accrued through the Company’s final payment.
	Long-Term Debt
	The components of long-term debt were as follows:
	(Dollars in millions)	September 30, 2013			December 31, 2012
	Principal Value:
	3.50% Notes due 2014	$	500		$	500
	4.90% Notes due 2019	700			700
	5.90% Notes due 2039	300			300
	Sub-total	1,500.00			1,500.00
	Adjustments to Principal Value:
	Unamortized basis adjustment for terminated interest rate swaps	19			26
	Unamortized bond discount	(2.2		)	(2.8		)
	Long-term debt	$	1,516.80		$	1,523.20
	Using quoted prices in markets that are not active, the Company determined that the fair value of its long-term debt was $1,615.9 million (Level 2) as of September 30, 2013.
	The components of interest expense-net were as follows:
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions)	2013			2012			2013			2012
	Interest expense	$	14.5		$	18.3		$	45.3		$	53.3
	Interest income	(2.2		)	(1.4		)	(6.4		)	(4.3		)
	Interest expense-net	$	12.3		$	16.9		$	38.9		$	49
	For the three and nine months ended September 30, 2013, capitalized interest was $1.5 million and $3.7 million, respectively, compared with no capitalized interest for the same periods in 2012.

DERIVATIVES_AND_OTHER_FINANCIA

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS	9 Months Ended
	Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS	DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS
	Derivatives
	The Company is exposed to market risk due to changes in currency exchange rates and interest rates. To manage that risk, the Company enters into certain derivative financial instruments, when available on a cost-effective basis, to hedge its underlying economic exposure. These financial instruments are in Level 2 of the fair value hierarchy for both periods presented. For the nine months ended September 30, 2013 and 2012, there were no transfers between levels in the fair value hierarchy. Derivative financial instruments are not used for speculative purposes.
	The following table summarizes the Company’s fair value of outstanding derivatives designated as hedging instruments:
	(In millions)
	Cash flow hedges:	Balance Sheet Location		September 30, 2013				December 31, 2012
	Foreign exchange contracts	Other assets		$	5.8			$	—
	Foreign exchange contracts	Accrued expenses		(0.5		)		(5.1		)
	Net asset/(liability) of derivatives designated as hedging instruments			$	5.3			$	(5.1	)
	The Company’s derivative financial instruments present certain market and counterparty risks; however, concentration of counterparty risk is mitigated as the Company uses a variety of major banks worldwide whose long-term debt is rated A or higher by Standard & Poor’s Rating Service, Fitch Ratings, or Moody’s Investors Service, Inc. In addition, only conventional derivative financial instruments are used. The Company would not be materially impacted if any of the counterparties to the derivative financial instruments outstanding at September 30, 2013 failed to perform according to the terms of its agreement. At this time, the Company does not require collateral or any other form of securitization to be furnished by the counterparties to its derivative financial instruments.
	Cash Flow Hedges-Foreign Exchange Contracts
	The Company uses foreign exchange contracts to hedge forecasted transactions, primarily intercompany purchases for up to 18 months, on certain foreign currencies and designates these derivative instruments as foreign currency cash flow hedges when appropriate. For the contracts that qualify as hedges of probable forecasted transactions, the effective portion of changes in fair value is temporarily reported in accumulated other comprehensive loss and recognized in earnings when the hedged item affects earnings.
	The Company assesses hedge effectiveness at inception and on a quarterly basis. These assessments determine whether derivatives designated as qualifying hedges continue to be highly effective in offsetting changes in the cash flows of hedged items. Any ineffective portion of the change in fair value is included in current period earnings. For the three and nine months ended September 30, 2013 and 2012, the impact of hedge ineffectiveness on earnings was not significant.
	The Company will discontinue cash flow hedge accounting when the forecasted transaction is no longer probable to occur on the originally forecasted date, or 60 days thereafter, or when the hedge is no longer effective. During the three and nine months ended September 30, 2013 and 2012, the Company did not discontinue any cash flow hedges.
	The effective portion of changes in the fair value of foreign exchange contracts is recognized in earnings when the hedged item affects earnings, in cost of products sold, or deemed ineffective, in other expenses/(income)—net. All of the Company’s foreign exchange contracts qualify as hedges of probable forecasted cash flows.
	As of September 30, 2013, the notional value of the Company’s outstanding foreign exchange forward contracts designated as hedging instruments was $201.1 million, with a fair value of $5.3 million in net assets. As of December 31, 2012, the notional value of the Company’s outstanding foreign exchange forward contracts designated as hedging instruments was $207.2 million, with a fair value of $5.1 million in net liabilities. The fair value of all foreign exchange forward contracts is based on quarter-end forward currency rates. The fair value of foreign exchange forward contracts should be viewed in relation to the fair value of the underlying hedged transactions and the overall reduction in exposure to fluctuations in foreign currency exchange rates.
	The change in accumulated other comprehensive loss and the impact on earnings from foreign exchange contracts that qualified as cash flow hedges were as follows:
	(In millions)	2013				2012
	Balance—January 1	$	(4.1	)		$	4.3
	Derivatives qualifying as cash flow hedges deferred in other comprehensive income	5.2				(9.5		)
	Derivatives qualifying as cash flow hedges reclassified to cost of products sold (effective portion)	5.7				(0.9		)
	Change in deferred taxes	(3.0		)		3.1
	Balance—September 30	$	3.8			$	(3.0	)
	At September 30, 2013, the balance of the effective portion of changes in fair value on foreign exchange forward contracts that qualified for cash flow hedge accounting included in accumulated other comprehensive income was $3.8 million, $3.6 million of which is expected to be reclassified into earnings within the next 12 months.
	Fair Value Hedges
	The Company may, from time to time, enter into fixed-to-floating interest rate swaps as part of its interest rate management strategy. The gain or loss on these swaps that are designated and qualify as fair value hedges will be recognized in current earnings and offset by the loss or gain on the hedged item. These swaps are recorded at fair value. The fair value of the interest rate swaps is the present value of the future cash flows calculated based on forecasted LIBOR rates from a third party bank including credit value adjustments.
	In November 2009, the Company executed several interest rate swaps to convert $700.0 million of the Company’s newly-issued fixed rate debt to be paid in 2014 and 2019 to variable rate debt. In November 2010, the Company terminated $200.0 million notional amount of fixed-to-floating interest rate swaps in exchange for cash of $15.6 million. In July 2011, the Company terminated the remaining $500.0 million notional amount of fixed-to-floating interest rate swaps in exchange for cash of $23.5 million. The related basis adjustments of the underlying hedged items are being recognized as a reduction of interest expense over the remaining life of the underlying debt. There were no interest rate swaps outstanding at September 30, 2013.
	The earnings impact and decrease in interest expense from interest rate swaps was as follows:
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions)	2013			2012			2013			2012
	Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense	(2.3	)		(2.3	)		(6.9	)		(7.0	)
	See Note 15 for discussion of the Company’s long-term debt.
	Other Financial Instruments
	The Company does not hedge the interest rate risk associated with money market funds which totaled $314.7 million and $520.7 million as of September 30, 2013 and December 31, 2012, respectively. Money market funds are classified as Level 2 in the fair value hierarchy and are included in cash and cash equivalents on the balance sheet. The money market funds have quoted market prices that are generally equivalent to par.

MARKETABLE_SECURITIES_Notes

MARKETABLE SECURITIES (Notes)	9 Months Ended
	Sep. 30, 2013
Schedule of Trading Securities and Other Trading Assets [Line Items]
Marketable Securities [Table Text Block]	MARKETABLE SECURITIES
	Cost basis for the Company’s equity securities is determined by the specific identification method. Realized and unrealized gains and losses on trading securities are included in other expenses/(income) - net in the Company’s consolidated statements of earnings.
	During the three months ended September 30, 2013, the Company sold all of its investments in equity securities classified as trading securities. The Company recognized gains on trading securities of $4.0 million and $3.7 million for the three months and nine months ended September 30, 2013, respectively.

EQUITY

EQUITY	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]
STOCK
	Changes in common shares and treasury stock were as follows:
	(In millions)	Common Shares			Treasury Stock			Cost of Treasury
		Issued						Stock
	Balance as of January 1, 2013	206			3.5			$	244.6
	Stock-based compensation	0.7			0.2			17.9
	Treasury stock purchases	—			1			76.6
	Balance as of September 30, 2013	206.7			4.7			$	339.1
	Balance as of January 1, 2012	205.1			1.4			$	89.7
	Stock-based compensation	0.9			0.2			15
	Treasury stock purchases	—			1.2			93.3
	Balance as of September 30, 2012	206			2.8			$	198
	The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and vesting of performance share awards and restricted stock units. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized using the first-in first-out method.
	On March 16, 2010, MJN’s board of directors approved the repurchase of up to $300.0 million of the Company’s common stock. From the date of such authorization through September 30, 2013, 4.2 million shares were repurchased at an average cost per share of $71.12. As of September 30, 2013, the Company had $2.1 million available under this authorization.
	On September 10, 2013, MJN’s board of directors approved a new share repurchase authorization of up to an additional $500.0 million of the Company’s common stock. As of September 30, 2013, the Company had $500.0 million available under this authorization.
	Changes in accumulated other comprehensive loss by component were as follows:
	(In millions)	Foreign Currency Translation Adjustments				Deferred Gains/(Losses) on Derivatives Qualifying as Hedges				Pension and Other Post-retirement Benefits			Total			Noncontrolling Interest					Redeemable Noncontrolling Interest
	Balance as of January 1, 2013	$	(14.6	)		$	(4.1	)		$	(168.3	)	$	(187.0	)	$	(0.2	)			$	—
	Deferred Gains/(Losses)	(58.8		)		5.2				0.8			(52.8		)	3.1			1		(11.1		)	1
	Reclassification Adjustment for	—				5.7				23.9			29.6			—					—
	(Gains)/Losses Included in Net
	Earnings
	Tax Benefit/(Expense)	5.1				(3.0		)		(6.6		)	(4.5		)	(1.1		)			—
	Balance as of September 30, 2013	$	(68.3	)		$	3.8			$	(150.2	)	$	(214.7	)	$	1.8				$	(11.1	)
	1 Represents foreign currency translation adjustments.
	Reclassification adjustments out of accumulated other comprehensive loss were as follows:
		Three Months Ended September 30,
		Affected Statement of Earnings Lines
	(In millions)	Cost of Products Sold				Selling, General and Administrative				Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts	$	0.5			$	—			$	—		$	—		$	(0.1	)		$	0.4
	Pension and Other Postretirement Benefit Plans:
	Actuarial Gains/(Losses)	(0.7		)		(1.3		)		(0.1		)				0.6				(1.5		)
	Prior Service Benefits					0.1							—			—				0.1
	Settlements	—				—				—			(2.5		)	1				(1.5		)
	Total Reclassifications	$	(0.2	)		$	(1.2	)		$	(0.1	)	$	(2.5	)	$	1.5			$	(2.5	)
		Nine Months Ended September 30, 2013
		Affected Statement of Earnings Lines
	(In millions)	Cost of Products Sold				Selling, General and Administrative				Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts	$	(5.7	)		$	—			$	—		$	—		$	1.7			$	(4.0	)
	Pension and Other Postretirement Benefit Plans:
	Actuarial Gains/(Losses)	(2.1		)		(3.6		)		(0.6		)	—			2				(4.3		)
	Prior Service Benefits					0.1														0.1
	Settlements	—				—				—			(17.7		)	6.6				(11.1		)
	Total Reclassifications	$	(7.8	)		$	(3.5	)		$	(0.6	)	$	(17.7	)	$	10.3			$	(19.3	)

CONTINGENCIES

CONTINGENCIES	9 Months Ended
	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES
	In the ordinary course of business, the Company is subject to lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters.
	The Company is not aware of any environmental, health or safety-related litigation or significant environmental, health and safety-related financial obligations or liabilities arising from current or former operations or properties that are likely to have a material impact on the Company’s business, financial position, results of operations or cash flows. Liabilities or obligations, which could require the Company to make significant expenditures, could arise in the future, however, as the result of, among other things, changes in, or new interpretations of, existing laws, regulations or enforcement policies, claims relating to on- or off-site contamination, or the imposition of unanticipated investigation or cleanup obligations.
	On November 14, 2011, the Company’s subsidiary Mead Johnson & Company, LLC (“MJC”) obtained final trial court approval of a nationwide class settlement with plaintiffs in eight putative consumer class actions that had been consolidated and transferred to the U.S. District Court for the Southern District of Florida.  The suits all involved allegations of false and misleading advertising with respect to certain Enfamil LIPIL infant formula advertising.  The settlement allowed consumers who purchased Enfamil LIPIL infant formula between October 13, 2005, and March 31, 2010, to receive infant formula or cash. The period for submitting claims has expired, and the total amount claimed by class members was less than $8.0 million. As a result and consistent with the Company’s previously reported obligations under the settlement agreement, MJC distributed the difference between $8.0 million and the total amount claimed in the form of infant formula to Feeding America, the nation’s largest domestic hunger relief charity.  MJC also agreed not to oppose, and the court approved, attorneys’ fees and expenses to plaintiffs’ counsel of $3.5 million and $140 thousand, respectively.  As previously reported, MJC agreed to pay costs of notice and settlement administration.  The trial court’s approval of the settlement was affirmed on appeal, and the settlement became final in October 2012. The distribution to class members was completed as of the end of the third quarter of 2013.
	As previously reported in the Company’s Annual Report on Form 10-K for fiscal year 2012, the Company was served with a lawsuit filed on October 16, 2012 in St. Clair County (Illinois) Circuit Court under the caption Shelby Schrack, et al. v. Mead Johnson Nutrition Company and Mead Johnson & Company, which lawsuit alleges that certain bacteria in powdered formula were responsible for the death of one infant and serious illness in two others and seeks unspecified monetary damages. These illnesses were widely publicized in December 2011 and January 2012. The infants allegedly consumed formula from batches that were extensively tested by the Company, the Centers for Disease Control (“CDC”) and the U.S. FDA. These tests detected no bacteria in our infant formula. The CDC further noted that while these bacteria have sometimes been found in formula, they also exist in the environment and may potentially cause illness through person to person contact or through contamination of infant feedings at the point of use. We believe that the claims in this matter are without merit, and we intend to defend such claims vigorously. Nevertheless, we cannot guarantee the outcome of this litigation. The Company is currently in settlement discussions with the plantiffs in this case.
	The Company records accruals for contingencies when it is probable that a loss will be incurred and can be reasonably estimated. Although MJN cannot predict with certainty the final resolution of these lawsuits, investigations and claims asserted against the Company, MJN does not believe any currently pending legal proceeding to which MJN is a party will have a material effect on the Company’s business or financial condition, although an unfavorable outcome in excess of amounts recognized as of September 30, 2013, with respect to one or more of these proceedings, could have a material effect on the Company’s results of operations and cash flows for the periods in which a loss is recognized.
	The China Antitrust Review, discussed in Note 8 above, was resolved during the third quarter of 2013. In connection with the China Antitrust Review, the NDRC assessed an administrative penalty of $33.4 million against the Company, which penalty was paid during the third quarter and is non-deductible for tax purposes. The Company accrued $7.4 million in the second quarter of 2013 in connection with this matter and recognized the remaining charge of $26.0 million upon final resolution in the third quarter.
	The Company has initiated an internal investigation of, and is voluntarily complying with an SEC request for documents relating to, certain business activities of the Company’s local subsidiary in China. The Company’s investigation is focused on certain expenditures that were made by the subsidiary in connection with the promotion of the Company’s products or may have otherwise been made and that may not have complied with Company policies and applicable U.S. and/or local laws. The Company has retained outside legal counsel to conduct the investigation, which is being overseen by a committee of independent members of the Company’s board of directors. At this time, the Company is unable to predict the scope, timing or outcome of this ongoing matter or any regulatory or legal actions that may be commenced related to this matter.

ACCOUNTING_POLICIES_Policies

ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill—During the third quarter of 2013 the Company changed its annual impairment testing date from January 1 to July 1, which did not result in any delay, acceleration or avoidance of an impairment charge. The Company believes that moving the goodwill impairment testing date to the third quarter is preferable because it better aligns the impairment testing with our annual and long-term planning timeline, which is a significant element in the testing process. The Company completed impairment testing in both the first and third quarters of 2013 and concluded that no impairment of goodwill exists (see Note 13).
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	Recently Adopted Accounting Standards—In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-02, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income, requiring entities to provide information about the amounts reclassified out of accumulated other comprehensive income by component. For significant reclassifications related to net income, the ASU required disclosure in the consolidated statement of earnings or within the footnotes. For other amounts, the ASU required a cross-reference to other disclosures that provide additional detail about those amounts. This ASU did not change the current requirements for reporting the consolidated statement of earnings or other comprehensive income in the financial statements. The Company adopted the required financial reporting presentation effective January 1, 2013.
	Recently Issued Accounting Standards—In March 2013, the FASB issued ASU No. 2013-05, Foreign Currency Matters (Topic 830), clarifying the applicable guidance for the release of the cumulative translation adjustment. ASU 2013-05 is effective for the Company in the period beginning January 1, 2014. The Company does not expect the adoption of this update to have a material effect on the consolidated financial statements.
	In July 2013, the FASB issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or Tax Credit Carryforward Exists. ASU 2013-11 requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. ASU 2013-11 is effective for the Company in the period beginning January 1, 2014 and the Company does not anticipate that the adoption of this standard will have a material impact on its consolidated financial statements.

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2013
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table presents the calculation of basic and diluted earnings per share:
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions, except per share data)	2013			2012			2013			2012
	Basic earnings per share:
	Weighted-average shares outstanding	202.3			203.7			202.5			203.9
	Net earnings attributable to shareholders	$	161.6		$	140.3		$	496.3		$	470.3
	Dividends and undistributed earnings attributable to unvested shares	(0.3		)	(0.3		)	(1.0		)	(1.1		)
	Net earnings attributable to shareholders used for basic earnings per share calculation	$	161.3		$	140		$	495.3		$	469.2
	Net earnings attributable to shareholders per share	$	0.8		$	0.69		$	2.45		$	2.3
	Diluted earnings per share:
	Weighted-average shares outstanding	202.3			203.7			202.5			203.9
	Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	0.5			0.6			0.6			0.6
	Weighted-average shares — diluted	202.8			204.3			203.1			204.5
	Net earnings attributable to shareholders	$	161.6		$	140.3		$	496.3		$	470.3
	Dividends and undistributed earnings attributable to unvested shares	(0.3		)	(0.3		)	(1.0		)	(1.1		)
	Net earnings attributable to shareholders used for diluted earnings per share calculation	$	161.3		$	140		$	495.3		$	469.2
	Net earnings attributable to shareholders per share	$	0.79		$	0.69		$	2.44		$	2.29

SEGMENT_INFORMATION_SEGMENT_IN

SEGMENT INFORMATION SEGMENT INFORMATION (Table) (Tables)	9 Months Ended
	Sep. 30, 2013
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]
		Three Months Ended September 30,										Nine Months Ended September 30,
		Net Sales				Earnings Before Interest and Income Taxes						Net Sales				Earnings Before Interest and Income Taxes
	(In millions)	2013		2012		2013			2012			2013		2012		2013			2012
	Asia/Latin America	$	768	$	646.7	$	262		$	193.1		$	2,280.70	$	2,056.00	$	770		$	713.9
	North America/Europe	278.8		274.6		63			53.2			859.3		864.2		187.7			157.2
	Total reportable segments	1,046.80		921.3		325			246.3			3,140.00		2,920.20		957.7			871.1
	Corporate and Other	—		—		(86.3		)	(63.1		)	—		—		(238.3		)	(190.8		)
	Total	$	1,046.80	$	921.3	$	238.7		$	183.2		$	3,140.00	$	2,920.20	$	719.4		$	680.3

EMPLOYEE_STOCK_BENEFIT_PLANS_T

EMPLOYEE STOCK BENEFIT PLANS (Tables)	9 Months Ended
	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of stock-based compensation expense by award type
		Three Months Ended September 30,							Nine Months Ended September 30,
	(In millions)	2013				2012			2013			2012
	Stock options	$	1.6			$	1.8		$	4.9		$	5.5
	Performance share awards	3.5				2			12.9			11.8
	Restricted stock units	2.2				2.1			7.9			6.5
	Total pre-tax stock-based compensation expense	$	7.3			$	5.9		$	25.7		$	23.8
	Net tax benefit related to stock-based compensation expense	$	(2.6	)		$	(2.5	)	$	(8.8	)	$	(9.1	)
Awards Granted and Weighted-Average Grant Date Fair Value of Options Granted
	(Shares in millions)	Shares Granted			Weighted-
					Average Grant
					Date Fair Value
	Stock options	0.5			$	15.08
	Performance share awards	0.2			$	72.53
	Restricted stock units	0.1			$	74.85
Unrecognized Compensation Costs Of Outstanding Share Awards
	(Dollars and shares in millions)	Unrecognized				Expected
		Compensation				Weighted-Average
		Expense				Period to be
						Recognized
						(years)
	Stock options	$	9.2			2
	Performance share awards	$	10.1			1.4
	Restricted stock units	$	15.3			2.6

PENSION_AND_OTHER_POSTRETIREME1

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Tables)	9 Months Ended
	Sep. 30, 2013
General Discussion of Pension and Other Postretirement Benefits [Abstract]
Schedule of net periodic benefit cost
		Three Months Ended September 30,											Nine Months Ended September 30,
		Pension Benefits						Other Benefits					Pension Benefits						Other Benefits
	(In millions)	2013			2012			2013			2012		2013			2012			2013			2012
	Service cost – benefits earned during the period	$	1.3		$	1		$	0.3		$	0.2	$	3.9		$	2.9		$	0.8		$	0.7
	Interest cost on projected benefit obligations	3.6			3.8			0.4			0.4		10.8			11.7			1			1
	Expected return on plan assets	(4.1		)	(4.2		)	—			—		(12.3		)	(12.1		)	—			—
	Amortization of net actuarial loss	1.7			1.4			0.4			0.4		5			4			1.3			1.4
	Amortization of prior service benefit	—			—			(0.1		)	—		—			—			(0.1		)	(0.1		)
	Net periodic benefit cost	$	2.5		$	2		$	1		$	1	$	7.4		$	6.5		$	3		$	3
	Settlements	2.5			4.1			—			—		17.7			13.1			—			—
	Total net periodic benefit cost	$	5		$	6.1		$	1		$	1	$	25.1		$	19.6		$	3		$	3
	Settlements reflect the recognition of losses that were previously deferred within accumulated other comprehensive loss attributable to plan participants who have received lump sum distributions during the plan year. Recognition of settlements is triggered when the amount paid for lump sum distributions from a plan exceeds the sum of service and interest cost for the plan year. Losses reclassified to settlements for the nine months ended September 30, 2013 and 2012, respectively, were related to the U.S. plans and were recognized within other expenses/(income)-net on the consolidated statements of earnings.

OTHER_EXPENSESINCOMENET_Tables

OTHER EXPENSES/(INCOME)-NET (Tables)	9 Months Ended
	Sep. 30, 2013
Other Income and Expenses [Abstract]
Components of other expenses/(income)-net
		Three Months Ended September 30,					Nine Months Ended September 30,
	(In millions)	2013		2012			2013		2012
	Foreign exchange (gains)/losses - net	$	2.1	$	6.7		$	6.9	$	(2.1	)
	Administrative penalty (China)	26		—			33.4		—
	Pension settlements	2.5		4.1			17.7		13.1
	Gain on sale of certain non-core intangible assets	—		(5.5		)	—		(5.5		)
	Other - net	0.8		4.3			4.6		8
	Other expenses/(income) - net	$	31.4	$	9.6		$	62.6	$	13.5
	As announced by the Company on August 6, 2013, China’s National Development and Reform Commission (“NDRC”) assessed an administrative penalty against the Company in connection with the NDRC’s antitrust review of the infant formula industry’s resale pricing practices (“China Antitrust Review”). All amounts assessed were paid in the third quarter of 2013.

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2013
Inventory Disclosure [Abstract]
Major categories of inventories	The major categories of inventories were as follows:
	(In millions)	September 30, 2013		December 31, 2012
	Finished goods	$	286.3	$	264.6
	Work in process	85.8		56.9
	Raw and packaging materials	127.5		114.4
	Inventories	$	499.6	$	435.9

PROPERTY_PLANT_AND_EQUIPMENT_T

PROPERTY, PLANT AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2013
Property, Plant and Equipment [Abstract]
Major categories of property, plant and equipment	The major categories of property, plant and equipment were as follows:
	(In millions)	September 30, 2013			December 31, 2012
	Land	$	6.6		$	6
	Buildings	521.5			506
	Machinery, equipment and fixtures	638.6			595.7
	Construction in progress	214.7			150.4
	Accumulated depreciation	(596.3		)	(568.2		)
	Property, plant and equipment — net	$	785.1		$	689.9
	Construction in progress included investment primarily for the Company’s new spray dryer and technology center in Singapore (“Asia Spray Dryer Project”).

GOODWILL_Tables

GOODWILL (Tables)	9 Months Ended
	Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]
Change in carrying amount of goodwill by reportable segment	For the nine months ended September 30, 2013 and 2012, the change in the carrying amount of goodwill by reportable segment, including the cumulative impact of the revisions described above, was as follows:
	(In millions)	Asia/			North America/			Total
		Latin America			Europe
	Balance as of January 1, 2013	$	253.6		$	17		$	270.6
	Redenomination	(42.5		)	2			(40.5		)
	Translation adjustments	(20.8		)	—			(20.8		)
	Balance as of September 30, 2013	$	190.3		$	19		$	209.3
	Balance as of January 1, 2012	$	115.8		$	1.7		$	117.5
	Acquisition	155.5			17.3			172.8
	Translation adjustments	(11.4		)	(1.3		)	(12.7		)
	Balance as of September 30, 2012	$	259.9		$	17.7		$	277.6

OTHER_INTANGIBLE_ASSETS_Tables

OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2013
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule of gross carrying value and accumulated amortization by class of intangible assets	The gross carrying value and accumulated amortization by class of intangible assets as of September 30, 2013 and December 31, 2012 were as follows:
		As of September 30, 2013							As of December 31, 2012
	(In millions)	Gross		Accumulated			Net Book		Gross		Accumulated			Net Book
		Carrying		Amortization			Value		Carrying		Amortization			Value
		Amount							Amount
	Indefinite-lived intangible assets:
	Trademark(1) .	$	38.5	$	—		$	38.5	$	45.3	$	—		$	45.3
	Non-compete agreement(1) .	7.6		—			7.6		8.9		—			8.9
	Sub-total	46.1		—			46.1		54.2		—			54.2
	Amortizable intangible assets:
	Computer software	132.2		(74.6		)	57.6		132.2		(60.2		)	72
	Distributor-customer relationship(1) .	3.7		(0.6		)	3.1		4.4		(0.7		)	3.7
	Sub-total	135.9		(75.2		)	60.7		136.6		(60.9		)	75.7
	Total other intangible assets	$	182	$	(75.2	)	$	106.8	$	190.8	$	(60.9	)	$	129.9

DEBT_Tables

DEBT (Tables)	9 Months Ended
	Sep. 30, 2013
Debt Disclosure [Abstract]
Components of long-term debt	The components of long-term debt were as follows:
	(Dollars in millions)	September 30, 2013			December 31, 2012
	Principal Value:
	3.50% Notes due 2014	$	500		$	500
	4.90% Notes due 2019	700			700
	5.90% Notes due 2039	300			300
	Sub-total	1,500.00			1,500.00
	Adjustments to Principal Value:
	Unamortized basis adjustment for terminated interest rate swaps	19			26
	Unamortized bond discount	(2.2		)	(2.8		)
	Long-term debt	$	1,516.80		$	1,523.20
Components of interest expense-net	The components of interest expense-net were as follows:
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions)	2013			2012			2013			2012
	Interest expense	$	14.5		$	18.3		$	45.3		$	53.3
	Interest income	(2.2		)	(1.4		)	(6.4		)	(4.3		)
	Interest expense-net	$	12.3		$	16.9		$	38.9		$	49

DERIVATIVES_AND_OTHER_FINANCIA1

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
	Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of outstanding derivatives	The following table summarizes the Company’s fair value of outstanding derivatives designated as hedging instruments:
	(In millions)
	Cash flow hedges:	Balance Sheet Location		September 30, 2013				December 31, 2012
	Foreign exchange contracts	Other assets		$	5.8			$	—
	Foreign exchange contracts	Accrued expenses		(0.5		)		(5.1		)
	Net asset/(liability) of derivatives designated as hedging instruments			$	5.3			$	(5.1	)
Schedule of change in accumulated other comprehensive income (loss) and the impact on earnings from foreign exchange contracts	The change in accumulated other comprehensive loss and the impact on earnings from foreign exchange contracts that qualified as cash flow hedges were as follows:
	(In millions)	2013				2012
	Balance—January 1	$	(4.1	)		$	4.3
	Derivatives qualifying as cash flow hedges deferred in other comprehensive income	5.2				(9.5		)
	Derivatives qualifying as cash flow hedges reclassified to cost of products sold (effective portion)	5.7				(0.9		)
	Change in deferred taxes	(3.0		)		3.1
	Balance—September 30	$	3.8			$	(3.0	)
Schedule of impact on earnings from interest rate swaps
		Three Months Ended September 30,						Nine Months Ended September 30,
	(In millions)	2013			2012			2013			2012
	Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense	(2.3	)		(2.3	)		(6.9	)		(7.0	)

EQUITY_Tables

EQUITY (Tables)	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]
Schedule of changes in common shares and treasury stock	Changes in common shares and treasury stock were as follows:
	(In millions)	Common Shares			Treasury Stock			Cost of Treasury
		Issued						Stock
	Balance as of January 1, 2013	206			3.5			$	244.6
	Stock-based compensation	0.7			0.2			17.9
	Treasury stock purchases	—			1			76.6
	Balance as of September 30, 2013	206.7			4.7			$	339.1
	Balance as of January 1, 2012	205.1			1.4			$	89.7
	Stock-based compensation	0.9			0.2			15
	Treasury stock purchases	—			1.2			93.3
	Balance as of September 30, 2012	206			2.8			$	198
Schedule of Changes in Accumulated Other Comprehensive Income by Component
	(In millions)	Foreign Currency Translation Adjustments				Deferred Gains/(Losses) on Derivatives Qualifying as Hedges				Pension and Other Post-retirement Benefits			Total			Noncontrolling Interest					Redeemable Noncontrolling Interest
	Balance as of January 1, 2013	$	(14.6	)		$	(4.1	)		$	(168.3	)	$	(187.0	)	$	(0.2	)			$	—
	Deferred Gains/(Losses)	(58.8		)		5.2				0.8			(52.8		)	3.1			1		(11.1		)	1
	Reclassification Adjustment for	—				5.7				23.9			29.6			—					—
	(Gains)/Losses Included in Net
	Earnings
	Tax Benefit/(Expense)	5.1				(3.0		)		(6.6		)	(4.5		)	(1.1		)			—
	Balance as of September 30, 2013	$	(68.3	)		$	3.8			$	(150.2	)	$	(214.7	)	$	1.8				$	(11.1	)
Schedule of Reclassification Adjustments out of AOCI
		Three Months Ended September 30,
		Affected Statement of Earnings Lines
	(In millions)	Cost of Products Sold				Selling, General and Administrative				Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts	$	0.5			$	—			$	—		$	—		$	(0.1	)		$	0.4
	Pension and Other Postretirement Benefit Plans:
	Actuarial Gains/(Losses)	(0.7		)		(1.3		)		(0.1		)				0.6				(1.5		)
	Prior Service Benefits					0.1							—			—				0.1
	Settlements	—				—				—			(2.5		)	1				(1.5		)
	Total Reclassifications	$	(0.2	)		$	(1.2	)		$	(0.1	)	$	(2.5	)	$	1.5			$	(2.5	)
		Nine Months Ended September 30, 2013
		Affected Statement of Earnings Lines
	(In millions)	Cost of Products Sold				Selling, General and Administrative				Research and Development			Other Expenses/ (Income) - Net			Tax Benefit/(Expense)				Net
	Deferred Gains/(Losses) on Derivatives Qualifying as Hedges:
	Forward Exchange Contracts	$	(5.7	)		$	—			$	—		$	—		$	1.7			$	(4.0	)
	Pension and Other Postretirement Benefit Plans:
	Actuarial Gains/(Losses)	(2.1		)		(3.6		)		(0.6		)	—			2				(4.3		)
	Prior Service Benefits					0.1														0.1
	Settlements	—				—				—			(17.7		)	6.6				(11.1		)
	Total Reclassifications	$	(7.8	)		$	(3.5	)		$	(0.6	)	$	(17.7	)	$	10.3			$	(19.3	)

EARNINGS_PER_SHARE_Details

EARNINGS PER SHARE (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Basic earnings per share:
Weighted-average shares outstanding	202.3	203.7	202.5	203.9
Net earnings attributable to shareholders	$161.60	$140.30	$496.30	$470.30
Dividends and undistributed earnings attributable to unvested shares	-0.3	-0.3	-1	-1.1
Net earnings attributable to shareholders used for basic earnings per share calculation	161.3	140	495.3	469.2
Net earnings attributable to shareholders per share	$0.80	$0.69	$2.45	$2.30
Diluted earnings per share:
Weighted-average shares outstanding	202.3	203.7	202.5	203.9
Incremental shares outstanding assuming the exercise/vesting of dilutive stock options/performance shares	0.5	0.6	0.6	0.6
Weighted-average shares - diluted	202.8	204.3	203.1	204.5
Net earnings attributable to shareholders	161.6	140.3	496.3	470.3
Dividends and undistributed earnings attributable to unvested shares	-0.3	-0.3	-1	-1.1
Net earnings attributable to shareholders used for diluted earnings per share calculation	$161.30	$140	$495.30	$469.20
Net earnings attributable to shareholders per share	$0.79	$0.69	$2.44	$2.29
Potential shares outstanding	2.9	2.8	2.9	2.8
Potential shares outstanding, not included in the diluted earnings per share calculation	2.4	2.2	2.3	2.2

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	29.40%	16.30%	26.80%	24.00%
Gross reserve for uncertain tax positions related to foreign and domestic matters, including penalties and interest	$102.80		$102.80		$75.90
Net receivable from BMS related to 2009 taxes	$8.80		$8.80		$8.50

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
			Segment
Segment Reporting [Abstract]
Number of geographic operating segments			4
Number of reportable segments			2
SEGMENT INFORMATION
Net Sales	$1,046.80	$921.30	$3,140	$2,920.20
Earnings Before Interest and Income Taxes	238.7	183.2	719.4	680.3
Asia/Latin America
SEGMENT INFORMATION
Net Sales	768	646.7	2,280.70	2,056
Earnings Before Interest and Income Taxes	262	193.1	770	713.9
North America/Europe
SEGMENT INFORMATION
Net Sales	278.8	274.6	859.3	864.2
Earnings Before Interest and Income Taxes	63	53.2	187.7	157.2
Total reportable segments
SEGMENT INFORMATION
Net Sales	1,046.80	921.3	3,140	2,920.20
Earnings Before Interest and Income Taxes	325	246.3	957.7	871.1
Corporate And Other
SEGMENT INFORMATION
Net Sales	0	0	0	0
Earnings Before Interest and Income Taxes	($86.30)	($63.10)	($238.30)	($190.80)

EMPLOYEE_STOCK_BENEFIT_PLANS_D

EMPLOYEE STOCK BENEFIT PLANS (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stock-based compensation expense
Total pre-tax stock-based compensation expense	$7.30	$5.90	$25.70	$23.80
Net tax benefit related to stock-based compensation expense	-2.6	-2.5	-8.8	-9.1
Stock options
Stock-based compensation expense
Total pre-tax stock-based compensation expense	1.6	1.8	4.9	5.5
Performance share awards
Stock-based compensation expense
Total pre-tax stock-based compensation expense	3.5	2	12.9	11.8
Restricted stock units
Stock-based compensation expense
Total pre-tax stock-based compensation expense	$2.20	$2.10	$7.90	$6.50

EMPLOYEE_STOCK_BENEFIT_PLANS_D1

EMPLOYEE STOCK BENEFIT PLANS (Details 2) (USD $)	9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2013
Stock Options
EMPLOYEE STOCK BENEFIT PLANS
Shares Granted	0.5
Weighted-Average Grant Date Fair Value (in dollars per share)	$15.08
Unrecognized Compensation Expense	$9.20
Expected Weighted-Average Period to be Recognized (in years)	2 years
Performance Share Awards
EMPLOYEE STOCK BENEFIT PLANS
Shares Granted	0.2
Weighted-Average Grant Date Fair Value (in dollars per share)	$72.53
Unrecognized Compensation Expense	10.1
Expected Weighted-Average Period to be Recognized (in years)	1 year 4 months 26 days
Restricted stock units
EMPLOYEE STOCK BENEFIT PLANS
Shares Granted	0.1
Weighted-Average Grant Date Fair Value (in dollars per share)	$74.85
Unrecognized Compensation Expense	$15.30
Expected Weighted-Average Period to be Recognized (in years)	2 years 7 months 9 days

PENSION_AND_OTHER_POSTRETIREME2

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Changes in net periodic benefit cost
Defined Benefit Plan, Contributions by Employer			$6.10	$24.90
Pension Benefits
Changes in net periodic benefit cost
Service cost - benefits earned during the period	1.3	1	3.9	2.9
Interest cost on projected benefit obligations	3.6	3.8	10.8	11.7
Expected return on plan assets	-4.1	-4.2	-12.3	-12.1
Amortization of net actuarial loss	1.7	1.4	5	4
Amortization of Prior Service Benefit	0	0	0	0
Net periodic benefit cost	2.5	2	7.4	6.5
Settlements	2.5	4.1	17.7	13.1
Total net periodic benefit cost	5	6.1	25.1	19.6
Other Benefits
Changes in net periodic benefit cost
Service cost - benefits earned during the period	0.3	0.2	0.8	0.7
Interest cost on projected benefit obligations	0.4	0.4	1	1
Expected return on plan assets	0	0	0	0
Amortization of net actuarial loss	0.4	0.4	1.3	1.4
Amortization of Prior Service Benefit	-0.1	0	-0.1	-0.1
Net periodic benefit cost	1	1	3	3
Settlements	0	0	0	0
Total net periodic benefit cost	$1	$1	$3	$3

OTHER_EXPENSESINCOMENET_Detail

OTHER EXPENSES/(INCOME)-NET (Details) (USD $)	3 Months Ended			9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Foreign exchange (gains)/losses-net	$2.10		$6.70	$6.90	($2.10)
Administrative penalty (China)	26	7.4	0	33.4	0
Nonoperating Income (Expense)	0		-5.5		-5.5
Other-net	0.8		4.3	4.6	8
Other Expenses/(Income)bnet	31.4		9.6	62.6	13.5
Pension Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Pension settlements	2.5		4.1	17.7	13.1
Total reportable segments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Nonoperating Income (Expense)				$0

REDEEMABLE_NONCONTROLLING_INTE1

REDEEMABLE NONCONTROLLING INTEREST (Details)	Sep. 30, 2013	Sep. 30, 2013	Mar. 15, 2012	Sep. 30, 2013
	Purchase Put Right	Sell Call Right	Nutricion para el Conosur S.A.	Indonesia
ACQUISITION
Percentage of outstanding shares of capital stock acquired			80.00%
Noncontrolling interests (as a percent)	20.00%	20.00%		10.00%

NET_EARNINGS_ATTRIBUTABLE_TO_N1

NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (Details)	Sep. 30, 2013
Argentina
Noncontrolling interest disclosures
Noncontrolling interests (as a percent)	20.00%
China
Noncontrolling interest disclosures
Noncontrolling interests (as a percent)	11.00%
Indonesia
Noncontrolling interest disclosures
Noncontrolling interests (as a percent)	10.00%

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Inventory Disclosure [Abstract]
Finished goods	$286.30	$264.60
Work in process	85.8	56.9
Raw and packaging materials	127.5	114.4
Inventories	$499.60	$435.90

PROPERTY_PLANT_AND_EQUIPMENT_D

PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Property, plant and equipment disclosures
Accumulated depreciation	($596.30)	($568.20)
Property, plant, and equipment-net	785.1	689.9
Land
Property, plant and equipment disclosures
Property, plant and equipment - gross	6.6	6
Buildings
Property, plant and equipment disclosures
Property, plant and equipment - gross	521.5	506
Machinery, equipment and fixtures
Property, plant and equipment disclosures
Property, plant and equipment - gross	638.6	595.7
Construction in progress
Property, plant and equipment disclosures
Property, plant and equipment - gross	$214.70	$150.40

GOODWILL_Details

GOODWILL (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Details of goodwill
Goodwill at the beginning of the period	$270.60	$117.50
Acquisition		172.8
Redenomination	-40.5
Translation adjustments	-20.8	-12.7
Goodwill at the end of the period	209.3	277.6
Goodwill, Impaired, Accumulated Impairment Loss	0
Asia/Latin America
Details of goodwill
Goodwill at the beginning of the period	253.6	115.8
Acquisition		155.5
Redenomination	-42.5
Translation adjustments	-20.8	-11.4
Goodwill at the end of the period	190.3	259.9
North America/Europe
Details of goodwill
Goodwill at the beginning of the period	17	1.7
Acquisition		17.3
Redenomination	2
Translation adjustments	0	-1.3
Goodwill at the end of the period	$19	$17.70

OTHER_INTANGIBLE_ASSETS_Detail

OTHER INTANGIBLE ASSETS (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Other intangible assets
Total	$46.10	$54.20
Amortizable intangible assets
Gross Carrying Amount	135.9	136.6
Accumulated Amortization	-75.2	-60.9
Net Book Value	60.7	75.7
Total other intangible assets, Gross Carrying Amount	182	190.8
Total other intangible assets, Net Book Value	106.8	129.9
Computer software
Amortizable intangible assets
Gross Carrying Amount	132.2	132.2
Accumulated Amortization	-74.6	-60.2
Net Book Value	57.6	72
Distributor-customer relationship
Amortizable intangible assets
Gross Carrying Amount	3.7	4.4
Accumulated Amortization	-0.6	-0.7
Net Book Value	3.1	3.7
Trademark
Other intangible assets
Total	38.5	45.3
Non-compete agreement
Other intangible assets
Total	$7.60	$8.90

DEBT_Details

DEBT (Details)	3 Months Ended	9 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Mar. 15, 2012	Sep. 30, 2013	Sep. 30, 2013
	USD ($)	USD ($)	USD ($)	Nutricion para el Conosur S.A.	Nutricion para el Conosur S.A.	Lower limit	Upper limit
					ARS
Line of credit facility disclosures
Line of Credit Facility, Description	5
Short-term borrowings	$2.60	$2.60	$161
Credit facility weighted average interest rate (as a percent)		1.53%
Line of Credit Facility, Interest Rate at Period End	22.00%	22.00%
Term of credit facility	30-Jun-16
Line of credit, maximum amount of outstanding borrowings and letters of credit permitted at any one time	500	500
Line of credit, potential maximum with Company's request and lender consent	750	750
Credit Facility covenant, consolidated total debt to consolidated EBITDA ratio, numerator(cannot exceed)		3.25
Credit Facility covenant, consolidated total debt to consolidated EBITDA ratio, denominator		1
Credit Facility covenant, consolidated EBITDA to consolidated interest expense ratio, numerator (cannot be less)		3
Credit Facility covenant, consolidated EBITDA to consolidated interest expense ratio, denominator		1
Description of interest rate basis		LIBOR
Range of margin added to base rate (as a percent)						0.08%	1.45%
Credit facility, commitment fee percentage		0.20%
Purchase price allocation, Total consideration transferred					850.7
Note payable, acquisition date					377.6
Note Payable	$0	$0	$26
Interest through March 15, 2013 Note Payable				14.00%
Stated rate (as a percent)				0.85%

DEBT_Details_2

DEBT (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Long-Term Debt
Principal value of long-term debt obligations	$1,500		$1,500		$1,500
Unamortized basis adjustment for terminated interest rate swaps	19		19		26
Unamortized bond discount	-2.2		-2.2		-2.8
Long-term debt	1,516.80		1,516.80		1,523.20
Long-term debt - fair value	1,615.90		1,615.90
Interest expense	14.5	18.3	45.3	53.3
Interest income	-2.2	-1.4	-6.4	-4.3
Interest expense-net	12.3	16.9	38.9	49
Interest Costs Capitalized	1.5	0	3.7	0
3.50% Notes due 2014
Long-Term Debt
Stated rate (as a percent)	3.50%		3.50%		3.50%
Principal value of long-term debt obligations	500		500		500
4.90% Notes due 2019
Long-Term Debt
Stated rate (as a percent)	4.90%		4.90%		4.90%
Principal value of long-term debt obligations	700		700		700
5.90% Notes due 2039
Long-Term Debt
Stated rate (as a percent)	5.90%		5.90%		5.90%
Principal value of long-term debt obligations	$300		$300		$300

DERIVATIVES_AND_OTHER_FINANCIA2

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified			Cash flow hedges	Cash flow hedges	Cash flow hedges	Cash flow hedges	Designated as hedging instruments	Designated as hedging instruments	Designated as hedging instruments	Designated as hedging instruments
			D	Foreign Currency Forward Contract	Foreign Exchange Contract [Member]	Foreign Exchange Contract [Member]	Cash flow hedges	Cash flow hedges	Cash flow hedges	Cash flow hedges
							Other assets	Other assets	Accrued expenses	Accrued expenses
Derivative disclosures
Cash flow hedges							$5.80	$0	($0.50)	($5.10)
Net asset/(liability) of derivatives designated as hedging instruments	5.3	-5.1
Maximum duration of foreign exchange contracts used to hedge intercompany purchases (in months)				18 months
Number of days from originally forecasted transaction date to discontinue cash flow hedge accounting			60
Notional					$201.10	$207.20

DERIVATIVES_AND_OTHER_FINANCIA3

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance			($4.10)	$4.30
Derivatives qualifying as cash flow hedges deferred in other comprehensive income	1.2	-5.4	5.2	-9.5
Derivatives qualifying as cash flow hedges reclassified to cost of products sold (effective portion)			5.7	-0.9
Change in deferred taxes			-3	3.1
Ending balance	3.8	-3	3.8	-3
Cash flow hedge included within accumulated other comprehensive loss expected to be reclassified within the next twelve months			$3.60

DERIVATIVES_AND_OTHER_FINANCIA4

DERIVATIVES AND OTHER FINANCIAL INSTRUMENTS (Details 3) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Nov. 30, 2009	Jul. 31, 2011	Nov. 30, 2010	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
In Millions, unless otherwise specified			Interest Rate Swaps	Interest Rate Swaps	Interest Rate Swaps	Interest Rate Swaps	Fair value hedges	Fair value hedges	Fair value hedges	Fair value hedges
					Terminated contracts	Terminated contracts	Interest Rate Swaps	Interest Rate Swaps	Interest Rate Swaps	Interest Rate Swaps
Interest rate swap fair value hedges
Basis for calculating fair value of swaps							LIBOR
Notional Amount of Underlying Debt			$0	$700
Notional Amount					500	200
Cash received					23.5	15.6
Amortization of basis adjustment for terminated interest rate swaps recognized in interest expense							-2.3	-2.3	-6.9	-7
Money market funds, classified as Level Two	$314.70	$520.70

MARKETABLE_SECURITIES_Details

MARKETABLE SECURITIES (Details) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013
Schedule of Trading Securities and Other Trading Assets [Line Items]
Trading Securities, Realized Gain	$4	$3.70

EQUITY_Details

EQUITY (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013
In Millions, except Per Share data, unless otherwise specified			Common Stock	Common Stock	Treasury Stock	Treasury Stock	Marchtwothousandtenrepurchase [Member]	Septembertwothousandthirteenrepurchase [Member] [Member]
							Treasury Stock	Treasury Stock
Changes in common shares and treasury stock
Common stock issued, balance at beginning of period	206.7	206	206	205.1
Treasury stock balance at beginning of period					3.5	1.4
Stock-based compensation			0.7	0.9	0.2	0.2
Treasury stock purchases			0	0	1	1.2
Common stock issued, balance at end of period	206.7	206	206.7	206
Treasury stock balance at end of period					4.7	2.8
Balance, beginning of period (in dollars )	$339.10	$244.60			$244.60	$89.70
Stock-based compensation (in dollars )					17.9	15
Treasury stock purchases (in dollars )					76.6	93.3
Balance, end of period (in dollars )	339.1	244.6			339.1	198
Shares authorized to be repurchased March 2010 to date (in dollars)							300	500
Shares repurchased March 2010 to date, shares							4.2
Shares repurchased March 2010 to date, average cost per share							$71.12
Remaining repurchased available under the authorization (in dollars)							$2.10	$500

EQUITY_ACCUMULATED_OTHER_COMPR

EQUITY ACCUMULATED OTHER COMPREHENSIVE INCOME CHANGES BY COMPONENT (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012	Dec. 31, 2011
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$220.10	$42.50	$220.10	$42.50	$29	($168)
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	3.8	-3	3.8	-3	-4.1	4.3
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax	-4.9	25.6	-66.8	-4.2
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the Period	1.2	-5.4	5.2	-9.5
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax	0	0	0.8	0
Reclassification Adjustment for (Gains)/Losses Included in Net Earnings			5.7	-0.9
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	4.5	5.9	23.9	18.4
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax	-0.6	-17.5	4	-12.2
Change in deferred taxes			-3	3.1
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax	0.5	-2.2	-6.6	-5.4
Stockholders' Equity Attributable to Parent	210.2		210.2		18.7
Redeemable Noncontrolling Interest
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax			-11.1
Redeemable Noncontrolling Interest Accumulated Other Comprehensive Income Loss	-11.1		-11.1		0
Foreign Currency Translation Adjustments
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest					-14.6
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax			-58.8
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax			5.1
Stockholders' Equity Attributable to Parent	-68.3		-68.3
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	3.8		3.8		-4.1
Deferred Gains/(Losses) on Derivatives Qualifying as Hedges for the Period			5.2
Reclassification Adjustment for (Gains)/Losses Included in Net Earnings			5.7
Change in deferred taxes			-3
Pension and Other Postretirement Benefits
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest					-168.3
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, before Tax			0.8
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax			23.9
Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax			-6.6
Stockholders' Equity Attributable to Parent	-150.2		-150.2
Accumulated Other Comprehensive Loss
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	-214.7	-143.8	-214.7	-143.8	-187	-133.1
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax			-52.8
Reclassification adjustment for (gains)/losses included in net earnings			29.6
Other Comprehensive Income (Loss), Tax			-4.5
Stockholders' Equity Attributable to Parent	-214.7		-214.7
Noncontrolling Interests
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	9.9	16	9.9	16	10.3	11.1
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax			3.1
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax			-1.1
Stockholders Equity Noncontrolling Interest Accumulated Other Comprehensive Income	$1.80		$1.80		($0.20)

EQUITY_Reclassification_adjust

EQUITY Reclassification adjustments out of Accumulated Other Comprehensive Income (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax	$0.50	$0.40	($5.70)	$0.90
Reclassification adjustment out of AOCI deferred gainloss on derivatives qualifying as hedges forward exchange contract - tax	-0.1		1.7
Reclassification adjustment out of AOCI deferred gainloss on derivatives qualifying as hedges forward exchange contract - after tax	0.4		-4
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	4.5	5.9	23.9	18.4
Reclassification Adjustments out of AOCI - tax	1.5		10.3
Reclassification Adjustments out of AOCI - after tax	-2.5		-19.3
Reclassification Adjustments out of AOCI Pension Other Postretirement Benefit Actuarial Gains Losses [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Benefit Cost-Tax	0.6		2
Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Benefit-after Tax	-1.5		-4.3
Other Comprehensive Income (Loss), Amortization, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost Recognized in Net Periodic Benefit Cost, before Tax	0.1		0.1
Reclassification Adjustments out of AOCI Pension Postretirement Benefit - settlements [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Benefit Cost-Tax	1		6.6
Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Benefit-after Tax	-1.5		-11.1
Selling, General and Administrative Expenses [Member]
Schedule of Equity Method Investments [Line Items]
Reclassification adjustments out of AOCI - pretax	-1.2		-3.5
Selling, General and Administrative Expenses [Member] | Reclassification Adjustments out of AOCI Pension Other Postretirement Benefit Actuarial Gains Losses [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	-1.3		-3.6
Other Comprehensive Income (Loss), Amortization, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost Recognized in Net Periodic Benefit Cost, before Tax	0.1		0.1
Other Research and Development Expense [Member]
Schedule of Equity Method Investments [Line Items]
Reclassification adjustments out of AOCI - pretax	-0.1		-0.6
Other Research and Development Expense [Member] | Reclassification Adjustments out of AOCI Pension Other Postretirement Benefit Actuarial Gains Losses [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	-0.1		-0.6
Other Operating Expense [Member]
Schedule of Equity Method Investments [Line Items]
Reclassification adjustments out of AOCI - pretax	-2.5		-17.7
Other Operating Expense [Member] | Reclassification Adjustments out of AOCI Pension Postretirement Benefit - settlements [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	-2.5		-17.7
Cost of Sales [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax	0.5		-5.7
Reclassification adjustments out of AOCI - pretax	-0.2		-7.8
Cost of Sales [Member] | Reclassification Adjustments out of AOCI Pension Other Postretirement Benefit Actuarial Gains Losses [Member]
Schedule of Equity Method Investments [Line Items]
Other Comprehensive Income (Loss), Reclassification, Pension and Other Postretirement Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Cost, before Tax	($0.70)		($2.10)

CONTINGENCIES_Details

CONTINGENCIES (Details) (USD $)	3 Months Ended			9 Months Ended		23 Months Ended
	Sep. 30, 2013	Jun. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
	Proceeding			Proceeding		November 14 2011 MJC [Member]
Commitments and Contingencies Disclosure [Abstract]
Minimum number of proceedings that could have a material impact	1			1
Loss Contingencies [Line Items]
Number of Class Action Suits Filed and Served						8
Total amount claimed by class members was less than $8.0million						$8,000,000
MJC distributed the difference between $8.0million and the amt claimed in the form of Infant Formula						8,000,000
Attorneys Fees Payable by Subsidiaries for Plaintiffs Counsel						3,500,000
Expenses Payable by Subsidiaries for Plaintiffs Counsel						140,000
Administrative penalty (China)	$26,000,000	$7,400,000	$0	$33,400,000	$0